Funding Round attributes
Semble, a UK-based healthtech software company, has successfully closed a $15 million Series B funding round to enhance its healthcare-focused software-as-a-service (SaaS) platform. The funding round was led by Mercia Ventures, with additional participation from Octopus Ventures, Smedvig Ventures, and Triple Point. Founded by Christoph Lippuner and Mikael Landau, Semble offers healthcare organizations a streamlined platform designed to integrate and automate a range of administrative tasks, reducing manual processes and enhancing the efficiency of care delivery.
The newly raised capital will enable Semble to expand its market presence across the UK and France, focusing on delivering seamless digital solutions for healthcare providers of varying sizes. The funding will also support the development of additional platform features, including automation and AI-driven tools aimed at alleviating the administrative burdens commonly faced by healthcare staff. This aligns with Semble’s mission to support healthcare professionals in prioritizing patient care over time-consuming operational tasks, ultimately improving patient outcomes through more efficient workflows.
Mercia Ventures, the lead investor in this Series B round, expressed confidence in Semble’s approach to digital transformation within healthcare, highlighting its potential to improve operational efficiency for medical practitioners. With the backing of these investors, Semble is well-positioned to further strengthen its SaaS platform, addressing key challenges in healthcare operations and setting a foundation for long-term growth in the industry.
This funding round builds on Semble’s ongoing commitment to advancing healthcare technology, providing medical providers with tools to streamline tasks, simplify administration, and focus on patient-centered care in an increasingly digital healthcare landscape.
